Mora Jaramillo, Cesar
Mora Jaramillo, Cesar was paid $688K by Medicaid between Jan 2018 and May 2024, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.
33Billing provider infoMORA JARAMILLO, CESAR
PROVIDENCE, RI 02905
PROVIDENCE, RI 02905
33aNPI1629341813assigned 02/17/2012
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$688K
24GClaims17,943
24DCodes billed23
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in Rhode Island
Rank by total paid#3 of 80
Median peer was paid$16K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,742 | $161K | |
| 2019 | 420 | $18K | |
| 2020 | 2,410 | $83K | |
| 2021 | 4,272 | $126K | |
| 2022 | 2,862 | $125K | |
| 2023 | 3,259 | $132K | |
| 2024incomplete | 978 | $43K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 54% | 7,960 | 7,690 | $368K |
| 87428 | 16% | 1,933 | 1,902 | $111K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.3% | 1,016 | 932 | $64K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.6% | 1,185 | 1,170 | $38K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.6% | 1,015 | 964 | $32K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 2.4% | 90 | 75 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 1,484 | 1,460 | $14K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 1,305 | 646 | $14K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 92 | 86 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 262 | 229 | $6K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 77 | 74 | $4K |
| 99051 | <1% | 130 | 126 | $3K |
11 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 55 | $2K |
| 81025 | <1% | 386 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 231 | $2K |
| 99201 | <1% | 48 | $2K | |
| G0467 | Community health center visit, returning patient | <1% | 33 | $1K |
| 81002 | <1% | 382 | $776.99 | |
| 93000 | <1% | 36 | $520.91 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 52 | $325.10 |
| 82962 | <1% | 105 | $188.32 | |
| 87210 | <1% | 13 | $46.06 | |
| 90674 | <1% | 53 | $2.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.